• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA DUXAP8 通过海绵吸附 miR-20b-5p/SOS1 轴抑制甲状腺乳头状癌细胞凋亡。

lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.

机构信息

Department of Thyroid Surgery, The First Hospital of Jilin University, Changchun, Jilin 130020, P.R. China.

出版信息

Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8015. Epub 2021 Mar 24.

DOI:10.3892/or.2021.8015
PMID:33760128
Abstract

Papillary thyroid carcinoma (PTC) is the most common type of cancer in the endocrine system. Long non‑coding RNAs (lncRNAs) are associated with PTC progression. Therefore, the present study aimed to identify a novel lncRNA involved in PTC. Herein, dysregulated lncRNAs were analyzed in The Cancer Genome Atlas (TCGA)‑thyroid cancer (THCA) data. Furthermore, the association between double homeobox A pseudogene 8 (DUXAP8) gene expression and disease stage, and prognosis of patients with PTC was evaluated using the GEPIA online database, while the correlation between DUXAP8 expression and the clinicopathological characteristics of patients with PTC was analyzed by Chi‑square test. In addition, the biological effect of DUXAP8 expression on cell proliferation and apoptosis was also investigated. The protein and mRNA/microRNA (miRNA)/lncRNA expression levels were assessed by western blot analysis and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR), respectively. The interaction between miR‑20b‑5p and DUXAP8 was verified using bioinformatics analysis, RNA RIP assay, dual luciferase reporter assay, western blot analysis and RT‑qPCR. The analysis of the TCGA‑THCA data revealed that DUXAP8 was one of the most significantly upregulated lncRNAs in PTC. This finding was further confirmed in tissues from patients with PTC. Increased DUXAP8 expression was associated with higher grade and poorer prognosis in patients with PTC. In PTC cell lines, silencing of DUXAP8 expression with small interfering RNA‑DUXAP8 (si‑DUXAP8) induced cell apoptosis and attenuated cell proliferation. Additionally, transfection of PTC cells with si‑DUXAP8 decreased the phosphorylation levels of MEK1/2 and ERK1/2, as well as downregulated the expression of son of sevenless 1 (SOS1), cyclin D1 (CCND1) and c‑Myc. The results of the present study also revealed that miR‑20b‑5p could directly target DUXAP8. DUXAP8 expression was positively associated with that of SOS1, c‑Myc and CCND1 in the TCGA‑THCA data, and DUXAP8 level was positively correlated with that of SOS1 in PTC tumor tissues. Finally, transfection of PTC cells with the SOS1 overexpression plasmid, pcDNA3.1‑SOS1, rescued the effects of si‑DUXAP8 on cell proliferation and apoptosis. The present study was the first to identify DUXAP8 as a novel upregulated lncRNA in PTC, and provided new insights in understanding the effect of the lncRNA‑miRNA‑mRNA network in PTC.

摘要

甲状腺癌 (PTC) 是内分泌系统中最常见的癌症类型。长链非编码 RNA (lncRNA) 与 PTC 进展有关。因此,本研究旨在鉴定一种参与 PTC 的新型 lncRNA。在此,分析了癌症基因组图谱 (TCGA)-甲状腺癌 (THCA) 数据中的失调 lncRNA。此外,使用 GEPIA 在线数据库评估了 DUXAP8 基因表达与 PTC 患者疾病分期和预后之间的关联,并用卡方检验分析了 DUXAP8 表达与 PTC 患者临床病理特征之间的相关性。此外,还通过 Western blot 分析和逆转录-定量聚合酶链反应 (RT-qPCR) 分别评估了 DUXAP8 表达对细胞增殖和凋亡的生物学影响。通过生物信息学分析、RNA 免疫沉淀 (RIP) 测定、双荧光素酶报告基因测定、Western blot 分析和 RT-qPCR 验证了 miR-20b-5p 与 DUXAP8 之间的相互作用。TCGA-THCA 数据分析显示,DUXAP8 是 PTC 中上调最显著的 lncRNA 之一。这一发现在 PTC 患者的组织中得到了进一步证实。在 PTC 细胞系中,用小干扰 RNA-DUXAP8(si-DUXAP8) 沉默 DUXAP8 表达可诱导细胞凋亡并抑制细胞增殖。此外,转染 PTC 细胞的 si-DUXAP8 降低了 MEK1/2 和 ERK1/2 的磷酸化水平,并下调了 son of sevenless 1(SOS1)、细胞周期蛋白 D1(CCND1) 和 c-Myc 的表达。本研究的结果还表明,miR-20b-5p 可直接靶向 DUXAP8。在 TCGA-THCA 数据中,DUXAP8 的表达与 SOS1、c-Myc 和 CCND1 的表达呈正相关,而在 PTC 肿瘤组织中,DUXAP8 水平与 SOS1 的表达呈正相关。最后,转染 PTC 细胞的 SOS1 过表达质粒 pcDNA3.1-SOS1,挽救了 si-DUXAP8 对细胞增殖和凋亡的影响。本研究首次鉴定 DUXAP8 为 PTC 中一种新型上调的 lncRNA,为理解 lncRNA-miRNA-mRNA 网络在 PTC 中的作用提供了新的见解。

相似文献

1
lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.长链非编码 RNA DUXAP8 通过海绵吸附 miR-20b-5p/SOS1 轴抑制甲状腺乳头状癌细胞凋亡。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8015. Epub 2021 Mar 24.
2
Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.长链非编码 RNA DUXAP8 通过 miR-223-3p 介导的 CXCR4 调节促进甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Bioengineered. 2021 Dec;12(1):496-506. doi: 10.1080/21655979.2021.1882134.
3
Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.长链非编码 RNA CASC9 通过海绵吸附 miR-488-3p 促进甲状腺乳头状癌细胞的增殖和转移。
Cancer Med. 2020 Mar;9(5):1830-1841. doi: 10.1002/cam4.2839. Epub 2020 Jan 13.
4
MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1.微小 RNA-23a 通过调节细胞周期蛋白 G1 抑制甲状腺乳头状癌的生长。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3431-3439. doi: 10.26355/eurrev_201904_17707.
5
LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer.LINC00311 通过靶向 miR-330-5p/TLR4 通路促进人甲状腺乳头状癌细胞癌干样特性。
Cancer Med. 2020 Feb;9(4):1515-1528. doi: 10.1002/cam4.2815. Epub 2020 Jan 2.
6
Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.长链非编码 RNA LINC00520 通过作为 microRNA-577 的竞争性内源性 RNA 增加 Sphk2 表达来加速甲状腺乳头状癌的进展。
Cell Cycle. 2020 Apr;19(7):787-800. doi: 10.1080/15384101.2020.1731062. Epub 2020 Feb 20.
7
A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.一种新的长链非编码 RNA n384546 通过作为 miR-145-5p 的竞争性内源性 RNA 来调节 AKT3,促进甲状腺乳头状癌的进展和转移。
Cell Death Dis. 2019 Jun 3;10(6):433. doi: 10.1038/s41419-019-1637-7.
8
Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.长链非编码 RNA SNHG22 通过与 microRNA-429 竞争结合增加 ZEB1 表达,促进甲状腺乳头状癌的恶性发展。
Cell Cycle. 2020 May;19(10):1186-1199. doi: 10.1080/15384101.2020.1749466. Epub 2020 Apr 19.
9
Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.长链非编码 RNA TTN-AS1 通过调节 miR-153-3p/ZNRF2 轴促进甲状腺乳头状癌的发生。
J Gene Med. 2019 May;21(5):e3083. doi: 10.1002/jgm.3083. Epub 2019 Mar 25.
10
Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.沉默长链非编码 RNA 烟酰胺核苷酸转氢酶反义 RNA 1 通过靶向 miR-199a-5p 抑制甲状腺乳头状癌细胞增殖、迁移和侵袭并促进细胞凋亡。
Endocr J. 2021 May 28;68(5):583-597. doi: 10.1507/endocrj.EJ20-0353. Epub 2021 Mar 20.

引用本文的文献

1
Dual roles of long non-coding RNAs in thyroid cancer: regulation of programmed cell death pathways.长链非编码RNA在甲状腺癌中的双重作用:对程序性细胞死亡途径的调控
Med Oncol. 2025 May 23;42(6):217. doi: 10.1007/s12032-025-02750-0.
2
Bayesian inference of sample-specific coexpression networks.贝叶斯推断样本特异性共表达网络。
Genome Res. 2024 Oct 11;34(9):1397-1410. doi: 10.1101/gr.279117.124.
3
Biomarkers in Thyroid Cancer: Emerging Opportunities from Non-Coding RNAs and Mitochondrial Space.甲状腺癌中的生物标志物:非编码 RNA 和线粒体空间带来的新机遇。
Int J Mol Sci. 2024 Jun 18;25(12):6719. doi: 10.3390/ijms25126719.
4
MicroRNA Expression Profiling-Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes.微小RNA表达谱分析——甲状腺乳头状癌亚型的潜在分子鉴别
Biomedicines. 2024 Jan 9;12(1):136. doi: 10.3390/biomedicines12010136.
5
MiR-20b Tissue Expression Level Displays the Diagnostic Value in Papillary Thyroid Carcinoma.MiR-20b组织表达水平在甲状腺乳头状癌中显示出诊断价值。
Med J Islam Repub Iran. 2023 Sep 18;37:101. doi: 10.47176/mjiri.37.101. eCollection 2023.
6
Bayesian Optimized sample-specific Networks Obtained By Omics data (BONOBO).通过组学数据获得的贝叶斯优化样本特异性网络(BONOBO)
bioRxiv. 2023 Nov 17:2023.11.16.567119. doi: 10.1101/2023.11.16.567119.
7
Pseudogenes in Cancer: State of the Art.癌症中的假基因:最新进展
Cancers (Basel). 2023 Aug 8;15(16):4024. doi: 10.3390/cancers15164024.
8
Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma.铜死亡相关长链非编码RNA预测甲状腺癌的预后和免疫反应。
Front Genet. 2023 Jul 4;14:1100909. doi: 10.3389/fgene.2023.1100909. eCollection 2023.
9
The dual role of microRNA (miR)-20b in cancers: Friend or foe?微小 RNA(miR)-20b 在癌症中的双重作用:是敌是友?
Cell Commun Signal. 2023 Jan 30;21(1):26. doi: 10.1186/s12964-022-01019-7.
10
The emerging role of miR-20b in human cancer and other disorders: Pathophysiology and therapeutic implications.miR-20b在人类癌症及其他疾病中的新作用:病理生理学及治疗意义
Front Oncol. 2022 Dec 13;12:985457. doi: 10.3389/fonc.2022.985457. eCollection 2022.